decisionhealth Newsletters, Part B News - 2006 Issue 9 (September)
Vendor can add some NOC drugs to CAP in January
Subscribe or sign in to view the full article.
Article Overview
This article covers a CMS policy update involving the competitive acquisition program (CAP) and the handling of not otherwise classified (NOC) drugs when a vendor adds items to the program. It is relevant to practices enrolled in CAP, billing and reimbursement teams, and readers tracking CMS program operations and claim-splitting mechanisms. The piece also discusses the general use of unlisted drug billing and the planned use of a special Q code to distinguish CAP-related claims from non-CAP claims.
Why This Topic Matters
The update affects how practices obtain certain drugs, how claims are separated for payment processing, and how CMS and vendors coordinate additions to the CAP drug list. It matters for organizations that bill for drug administration and need to stay aligned with current CMS program requirements.
What You Will Learn
- How CMS is changing the handling of certain drugs under CAP
- How CAP participation affects drug acquisition and billing workflows
- What general claim-processing changes are associated with CAP-related NOC drugs
- How vendor and CMS roles are described in the CAP update
Who Should Read This
- Medical coders
- Billing specialists
- Practice managers
- Reimbursement staff
- CMS policy readers
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com